CADL Archived Articles

Candel Therapeutics' Resilience Shines Through with Landmark Prostate Cancer Trial Success


Candel Therapeutics (NASDAQ:CADL): A Pioneer in Multimodal Biological Immunotherapies


Candel Therapeutics, Inc. (CADL): Advancing Viral Immunotherapies to Fight Cancer